Revised Outcome of the Board Meeting held on 07th July, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Inject Kerala Limited issued a revised outcome of its board meeting held on July 7, 2025, correcting an earlier error regarding the CFO appointment date. The board appointed Mr. Rushiraj Zaverbhai Patel and Mr. Nileshbhai V. Rangholiya as Additional Independent Directors for a 5-year term each, effective July 7, 2025. Mr. Dipak Diwan was appointed as an Additional Executive Director for 5 years from July 7, 2025, and additionally as Chief Financial Officer (CFO) effective July 15, 2025. All appointments are subject to shareholder approval. The company clarified that none of the appointees are related to the promoters or promoter group and none are debarred by SEBI from holding director positions.
This is a routine corporate governance update involving the expansion of the board with two new independent directors and a new executive director/CFO. The revision only corrects an administrative typographical error in the original filing, with no material change for shareholders. No immediate impact on stock price is expected from this disclosure.